On the other hand, we observed that the frequency of delta ALT over the RCV cut-off was much lower in MetS(+) subjects than the frequency of delta ALT below the RCV (19% vs. 81%, Figure 1A). The gene discussed is GPT; the disease is metabolic syndrome.